Skip to content

Comparison of two accepted pre-operative radiation treatment schedules in rectal cancer.

Conventional VS hypo-fractionated pre-operative radiation treatment schedules in locally advanced rectal cancer - a prospective comparative study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2013/09/004035
Enrollment
60
Registered
2013-09-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Biopsy proven rectal carcinoma stages II & III. ECOG performance status 0 to 3.

Interventions

Control Intervention1: CONVENTIONAL VS HYPO-FRACTIONATED PRE-OPERATIVE RADIATION TREATMENT SCHEDULES: The investigator will observe those patients receiving pre-operative Radiotherapy of 25Gy in 5 fra

Sponsors

Government Medical College Thiruvananthapuram
Lead Sponsor
Dr Bonny Natesh
Collaborator
Dr V S Santhosh
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with biopsy proven rectal carcinoma stages II & III receiving either short-course or long-course of radiotherapy will be included in this study. 2.Patients with ECOG performance status 0 to 3. 3.Absolute granulocyte count more than 2000/mm3. 4.Platelet count greater than 100,000/mm3. 5.Renal function tests and Liver function tests are within normal limits.

Exclusion criteria

Exclusion criteria: 1.Patients with metastatic disease on diagnostic imaging during the course of study. 2.Patients with previous history of radiotherapy& treatment for GIT malignancy & history of chemotherapy. 3.Patients with history of treatment for any malignancy. 4.Associated serious medical illness like xerodermapigmentosa, renal failure, cardiac failure, hepatic failure. 5.Not giving consent.

Design outcomes

Primary

MeasureTime frame
toxicity profile and extend of local control of the diseaseTimepoint: at the end of every two months following treatment completion

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr Sabarinath P S

Govt. medical college, Thiruvananthapuram

sabarinathps@yahoo.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026